{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-011342","form_type":"8-K","ticker":null,"cik":"0000931059","company_name":"Rennova Health, Inc.","filed_at":"2024-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.337645+00:00","generated_at":"2026-06-04T08:17:30.522230+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Rennova Health reports expiration of ~403.8B shares of warrants, extends 101.35B Series B warrants to Dec 2025","bullets":["Warrants to purchase ~403.8 billion shares (Series A, B, C) expired on March 21, 2024, reducing potential dilution.","Series B warrants for 101.35 billion shares extended from March 21, 2024 to December 31, 2025, subject to exercise conditions.","Exercise conditions require specified share volumes exercised by dates from April 2024 to August 2025; no cashless exercise counts.","CEO Seamus Lagan stated the expiration significantly reduces potential dilution and the extension preserves capital access if conditions permit."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-011342","json":"https://secwatch.observer/filing/0001493152-24-011342.json","markdown":"https://secwatch.observer/filing/0001493152-24-011342.md","text":"https://secwatch.observer/filing/0001493152-24-011342.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/931059/000149315224011342/0001493152-24-011342-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/931059/000149315224011342/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T08:17:30.522230+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"005bbb965e089a39436a630c85667e8802d85b3f","claim":"Rennova Health, Inc. amended Series B Warrants with certain institutional holders (effective 2024-03-20).","evidence_excerpt":"On March 20, 2024, Rennova Health, Inc. (the “Company”) and certain institutional holders agreed that, with respect to Series B Warrants (originally issued on March 21, 2017), to acquire 101,350,000,000 shares of common stock, the termination date of such warrants would be extended from March 21, 2024 to December 31, 2025","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/931059/000149315224011342/0001493152-24-011342-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"certain institutional holders"},{"label":"Effective","value":"2024-03-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}